Prana Biotechnology Limited (PBT) Company Profile

Prana Biotechnology Limited Company Snapshot

Prana Biotechnology Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Prana Biotechnology Limited with three other pharmaceutical manufacturers in Australasia: Prescient Therapeutics Ltd (2017 sales of 166,220.00 Australian Dollars [US$129,354.07 ] ), Black Star Petroleum Ltd (122.00 Australian Dollars [US$94.94 ] ), and MGC Pharmaceuticals Ltd (247,500.00 Australian Dollars [US$192,606.98 ] ).

Sales Analysis. During the year ended June of 2017, sales at Prana Biotechnology Limited were A$132,396.00 (US$103.03 thousand). This is a decrease of 7.2% versus 2016, when the company's sales were A$142,657.00 .

Prana Biotechnology Limited

Stock Data:

Recent Stock Performance:

Current Price (4/20/2018): .04
(Figures in Australian Dollars)

1 Week	-4.4%	13 Weeks	-12.2%

4 Weeks	-28.3%	52 Weeks	-29.5%

Prana Biotechnology Limited Key Data:

Ticker:	PBT	Country:	Australia

Exchanges:	FRA OTC	Major Industry:	Pharmaceuticals & Biotechnology

		Sub Industry:	Pharmaceutical Preparations

2017 Sales	132,396 (Year Ending Jan 2018).	Employees:	15

Currency:	Australian Dollars	Market Cap:	22,957,333

Fiscal Yr Ends:	June	Shares Outstanding:	533,891,470

Share Type:	Ordinary	Closely Held Shares:	71,303,391

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.